As of 2024-12-14, the Intrinsic Value of Qiagen NV (QGEN) is
49.65 USD. This QGEN valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 45.40 USD, the upside of Qiagen NV is
9.40%.
The range of the Intrinsic Value is 31.64 - 111.32 USD
49.65 USD
Intrinsic Value
QGEN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
31.64 - 111.32 |
49.65 |
9.4% |
| DCF (Growth 10y) |
36.71 - 118.04 |
55.20 |
21.6% |
| DCF (EBITDA 5y) |
52.78 - 61.48 |
58.90 |
29.7% |
| DCF (EBITDA 10y) |
54.64 - 67.30 |
62.40 |
37.4% |
| Fair Value |
10.45 - 10.45 |
10.45 |
-76.98% |
| P/E |
13.05 - 55.46 |
33.38 |
-26.5% |
| EV/EBITDA |
50.92 - 59.45 |
56.09 |
23.5% |
| EPV |
21.32 - 27.75 |
24.53 |
-46.0% |
| DDM - Stable |
5.04 - 19.00 |
12.02 |
-73.5% |
| DDM - Multi |
28.51 - 82.82 |
42.33 |
-6.8% |
QGEN Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
10,090.60 |
| Beta |
0.52 |
| Outstanding shares (mil) |
222.26 |
| Enterprise Value (mil) |
11,037.46 |
| Market risk premium |
4.60% |
| Cost of Equity |
7.89% |
| Cost of Debt |
4.25% |
| WACC |
7.31% |